AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3729-3735

  Baucheron, Sylvie ^a   Tyler, Shaun ^b   Boyd, David ^b   Mulvey, Michael R ^b   Chaslus Dancla, Elisabeth ^a   Cloeckaert, Axel ^a  

^a CEMAGREF   (France)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENROFLOXACIN; FLORFENICOL; FLUMEQUINE; FLUOROPYRIMIDINE; MARBOFLOXACIN; MEMBRANE PROTEIN; MUTANT PROTEIN; NALIDIXIC ACID; POLYCLONAL ANTIBODY; PROTEIN ACRAB; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TOLC PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE TYPING; CONTROLLED STUDY; GENE CLUSTER; GENE MUTATION; GENETIC RESISTANCE; GENOMIC ISLAND; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; WESTERN BLOTTING;

BACTERIAL PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM;

EID: 4644351584     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3729-3735.2004     Document Type: Article

References (48)

1. Andersen, C., C. Hughes, and V. Koronakis. 2002. Electrophysiological behavior of the TolC channel-tunnel in planar lipid bilayers. J. Membr. Biol. 185:83-92.
2. Andersen, C., E. Koronakis, E. Bokma, J. Eswaran, D. Humphreys, C. Hughes, and V. Koronakis. 2002. Transition to the open state of the TolC periplasmic tunnel entrance. Proc. Natl. Acad. Sci. USA 99:11103-11108.
3. Andersen, C., E. Koronakis, C. Hughes, and V. Koronakis. 2002. An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol. Microbiol. 44:1131-1139.
4. Arcangioli, M. A., S. Leroy-Sétrin, J. L. Martel, and E. Chaslus-Dancla. 1999. A new chloramphenicol and florfenicol resistance gene flanked by two integron structures in Salmonella Typhimurium DT104. FEMS Microbiol. Lett. 174:327-332.
5. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:281-289.
6. Besser, T. E., M. Goldoft, L. C. Pritchett, R. Khakhria, D. D. Hancock, D. H. Rice, J. M. Gay, W. Johnson, and C. C. Gay. 2000. Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States. Epidemiol. Infect. 124:193-200.
7. Bolton, L. F., L. C. Kelley, M. D. Lee, P. J. Fedorka-Cray, and J. J. Maurer. 1999. Detection of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 based on a gene which confers cross-resistance to florfenicol and chloramphenicol. J. Clin. Microbiol. 37:1348-1351.
8. Boyd, D., G. A. Peters, A. Cloeckaert, K. S. Boumedine, E. Chaslus-Dancla, H. Imberechts, and M. R. Mulvey. 2001. Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J. Bacteriol. 183:5725-5732.
9. Boyd, D. A., G. A. Peters, L. Ng, and M. R. Mulvey. 2000. Partial characterization of a genomic island associated with the multidrug resistance region of Salmonella enterica Typhimurium DT104. FEMS Microbiol. Lett. 189:285-291.
10. Briggs, C. E., and P. M. Fratamico. 1999. Molecular characterization of an antibiotic resistance gene cluster of Salmonella Typhimurium DT104. Antimicrob. Agents Chemother. 43:846-849.
11. Carnevale, R., K. Molbak, F. Bager, and F. M. Aarestrup. 2000. Fluoroquinolone resistance in Salmonella: a web discussion. Clin. Infect. Dis. 31:128-130.
12. Cloeckaert, A., and E. Chaslus-Dancla. 2001. Mechanisms of quinolone resistance in Salmonella. Vet. Res. 32:291-300.
13. Cloeckaert, A., and S. Schwarz. 2001. Molecular characterization, spread and evolution of multidrug resistance in Salmonella enterica Typhimurium DT104. Vet. Res. 32:301-310.
14. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
15. Davis, M. A., D. D. Hancock, T. E. Besser, D. H. Rice, J. M. Gay, C. Gay, L. Gearhart, and R. DiGiacomo. 1999. Changes in antimicrobial resistance among Salmonella enterica serovar Typhimurium isolates from humans and cattle in the northwestern United States, 1982-1997. Emerg. Infect. Dis. 5:802-806.
16. Elkins, C. A., and H. Nikaido. 2003. 3D structure of AcrB: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm. Drug Resist. Update 6:9-13.
17. Elkins, C. A., and H. Nikaido. 2002. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J. Bacteriol. 184:6490-6498.
18. Eswaran, J., C. Hughes, and V. Koronakis. 2003. Locking TolC entrance helices to prevent protein translocation by the bacterial type I export apparatus. J. Mol. Biol. 327:309-315.
19. Favre, D., and J. F. Viret. 2000. Gene replacement in gram-negative bacteria: the pMAKSAC vectors. BioTechniques 28:198-204.
20. Fujihira, E., N. Tamura, and A. Yamaguchi. 2002. Membrane topology of a multidrug efflux transporter, AcrB, in Escherichia coli. J. Biochem. 131:145-151.
21. Giraud, E., A. Brisabois, J. L. Martel, and E. Chaslus-Dancla. 1999. Comparative studies of mutations in animal isolates and experimental in vitro-and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:2131-2137.
22. Giraud, E., A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
23. Glynn, M. K., C. Bopp, W. Dewitt, P. Dabney, M. Mokhtar, and F. J. Angulo. 1998. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N. Engl. J. Med. 338:1333-1338.
24. Hancock, D., T. Besser, J. Gay, D. Rice, M. Davis, and C. Gay. 2000. The global epidemiology of multiresistant Salmonella enterica serovar Typhimurium DT104, p. 217-243. In C. Brown and C. Bolin (ed.), Emerging diseases of animals. ASM Press, Washington, D.C.
25. Koronakis, V., C. Andersen, and C. Hughes. 2001. Channel-tunnels. Curr. Opin. Struct. Biol. 11:403-407.
26. Koronakis, V., A. Sharff, E. Koronakis, B. Luisi, and C. Hughes. 2000. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914-919.
27. Lacroix, F. J. 1995. Résistance de Salmonella Typhimurium aux détergents biologiques et chimiques: effet sur la colonisation intestinale et mise en évidence d'un gène de type acrB/F de Escherichia coli. Ph.D. thesis. Université Bordeaux I, Bordeaux, France.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Lee, A., W. Mao, M. S. Warren, A. Mistry, K. Hoshino, R. Okumura, H. Ishida, and O. Lomovskaya. 2000. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J. Bacteriol. 182:3142-3150.
30. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Biais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
31. Lomovskaya, O., and W. Watkins. 2001. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3:225-236.
32. Lomovskaya, O., H. I. Zgurskaya, and H. Nikaido. 2002. It takes three to tango. Nat. Biotechnol. 20:1210-1212.
33. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nikaido. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44:3441-3443.
34. Members of the SFM Antibiogram Committee. 2003. Comité de l'Antibiogramme de la Société Française de Microbiologie Report 2003. Int. J. Antimicrob. Agents 21:364-391.
35. Molbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N. Engl. J. Med. 341:1420-1425.
36. Murakami, S., R. Nakashima, E. Yamashita, and A. Yamaguchi. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593.
37. Murakami, S., and A. Yamaguchi. 2003. Multidrug-exporting secondary transporters. Curr. Opin. Struct. Biol. 13:443-452.
38. Oethinger, M., W. V. Kern, A. S. Jellen-Ritter, L. M. McMurry, and S. B. Levy. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13.
39. Palmer, M. 2003. Efflux of cytoplasmically acting antibiotics from gramnegative bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their cooperative action with single-component transporters. J. Bacteriol. 185:5287-5289.
40. Poppe, C., N. Smart, R. Khakhria, W. Johnson, J. Spika, and J. Prescott. 1998. Salmonella Typhimurium DT104: a virulent and drug-resistant pathogen. Can. Vet. J. 39:559-565.
41. Schmieger, H. 1972. Phage P22-mutants with increased or decreased transduction abilities. Mol. Gen. Genet. 119:75-88.
42. Tauxe, R. V. 1999. Salmonella Enteritidis and Salmonella Typhimurium DT104: successful subtypes in the modern world, p. 37-53. In W. M. Scheld, W. A. Craig, and J. M. Hughes (ed.), Emerging infections, vol. 3. ASM Press, Washington, D.C.
43. Threlfall, E. J. 2000. Epidemic Salmonella Typhimurium DT104: a truly international multiresistant clone. J. Antimicrob. Chemother. 46:7-10.
44. Tikhonova, E. B., Q. Wang, and H. I. Zgurskaya. 2002. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. J. Bacteriol. 184:6499-6507.
45. Walker, R. A., A. J. Lawson, E. A. Lindsay, L. R. Ward, P. A. Wright, F. J. Bolton, D. R. Wareing, J. D. Corkish, R. H. Davies, and E. J. Threlfall. 2000. Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella Typhimurium DT104. Vet. Rec. 147:395-396.
46. Yu, E. W., J. R. Aires, and H. Nikaido. 2003. AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J. Bacteriol. 185:5657-5664.
47. Yu, E. W., G. McDermott, H. I. Zgurskaya, H. Nikaido, and D. E. Koshland, Jr. 2003. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300:976-980.
48. Zgurskaya, H. I., and H. Nikaido. 2002. Mechanistic parallels in bacterial and human multidrug efflux transporters. Curr. Protein Pept. Sci. 3:531-540.